Ticker > Company >

Poly Medicure share price

Poly Medicure Ltd.

NSE: POLYMED BSE: 531768 SECTOR: Medical Equipment/Supplies/Accessories  121k   563   80

2235.00
+0.50 (0.02%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 2260

Today's Low

₹ 2202.05

52 Week High

₹ 3350

52 Week Low

₹ 1788.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

22646.3 Cr.

Enterprise Value

22669.93 Cr.

No. of Shares

10.13 Cr.

P/E

68.35

P/B

8.25

Face Value

₹ 5

Div. Yield

0.16 %

Book Value (TTM)

₹  270.83

CASH

136.95 Cr.

DEBT

160.58 Cr.

Promoter Holding

62.44 %

EPS (TTM)

₹  32.7

Sales Growth

22.4%

ROE

18.74 %

ROCE

23.28%

Profit Growth

40.59 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.4%
3 Year20.49%
5 Year17.38%

Profit Growth

1 Year40.59%
3 Year24.8%
5 Year30.59%

ROE%

1 Year18.74%
3 Year16.22%
5 Year18.05%

ROCE %

1 Year23.28%
3 Year20.1%
5 Year21.31%

Debt/Equity

0.1104

Price to Cash Flow

88.43

Interest Cover Ratio

27.0626

CFO/PAT (5 Yr. Avg.)

1.02981432982458

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 62.44 0.00
Dec 2024 62.44 0.00
Sep 2024 62.56 0.00
Jun 2024 66.03 0.00
Mar 2024 53.15 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 24.7972058112099% for the Past 3 years.
  • The company has shown a good revenue growth of 20.4863049196268% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 20.0998010608627% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 27.0626.
  • The Company has been maintaining an effective average operating margins of 25.7636935571738% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 35.1607 days.
  • Company has a healthy liquidity position with current ratio of 2.1596.
  • The company has a good cash flow management; CFO/PAT stands at 1.02981432982458.
  • The company has a high promoter holding of 62.44%.

 Limitations

  • The company is trading at a high PE of 68.35.
  • The company is trading at a high EV/EBITDA of 42.3686.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 360.93 367.43 402.47 410.94 420.97
Total Expenditure 263.64 266.23 289.54 295.34 304.93
Operating Profit 97.28 101.2 112.93 115.6 116.04
Other Income 15.66 16.83 27.24 21.75 23.95
Interest 2.93 2.98 3.13 3.13 2.17
Depreciation 16.04 18.98 20.11 20.83 21.33
Exceptional Items 0 0 0 0 0
Profit Before Tax 93.97 96.07 116.93 113.39 116.5
Tax 23.44 23.77 29.71 28.24 29.84
Profit After Tax 70.53 72.3 87.22 85.15 86.66
Adjusted EPS (Rs) 7.35 7.53 8.61 8.4 8.55

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 646.16 747.38 879.36 1068.05 1307.25
Total Expenditure 483.92 537.03 665.47 801.67 955.63
Operating Profit 162.24 210.36 213.89 266.37 351.62
Other Income 18.58 19.29 38.73 36.29 58.18
Interest 19.76 9.95 5.36 10.19 12.85
Depreciation 39.28 46.31 52.54 55.64 62.05
Exceptional Items 0 0 0 0 0
Profit Before Tax 121.78 173.38 194.72 236.83 334.89
Tax 29.4 43.87 48.7 57.78 83.17
Net Profit 92.38 129.51 146.02 179.04 251.72
Adjusted EPS (Rs.) 10.47 13.51 15.23 18.66 26.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 44.12 47.94 47.95 47.97 47.99
Total Reserves 385.16 906.07 1029.02 1186.15 1410.26
Borrowings 110.57 59.74 30.56 11.56 1.09
Other N/C liabilities 23.92 21.67 23.15 23.13 34.48
Current liabilities 208.27 195.54 203.27 326.81 400.35
Total Liabilities 772.05 1230.96 1333.96 1595.63 1894.16
Assets
Net Block 324.16 384.97 447.46 597.43 830.82
Capital WIP 16.7 14.74 37.11 72.53 66.67
Intangible WIP 7.88 6.43 5.86 5.21 4.04
Investments 42.03 39.8 46.94 56.96 81.07
Loans & Advances 19.54 12.73 31.85 41.89 38.63
Other N/C Assets 36.33 55.06 23.75 8.49 8.33
Current Assets 325.4 717.23 740.99 813.13 864.59
Total Assets 772.05 1230.96 1333.96 1595.63 1894.16
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 121.78 173.38 194.72 236.83 334.89
Adjustment 50.36 44.94 38.6 60.17 35.82
Changes in Assets & Liabilities -9.66 -57.79 -60.19 -42.33 -40.87
Tax Paid -35.58 -44.14 -46.86 -57.84 -73.74
Operating Cash Flow 126.91 116.4 126.26 196.83 256.1
Investing Cash Flow -105.67 -434.41 -88.71 -189.18 -237.02
Financing Cash Flow -22.25 318.92 -39.71 -7.89 -17.32
Net Cash Flow -1.02 0.9 -2.16 -0.25 1.76

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 53.15 66.03 62.56 62.44 62.44
aaryaman baid 0.29 0.29 0.28 0.28 0.28
arham baid 0.29 0.29 0.28 0.28 0.28
dhruv baid 0.38 0.38 0.36 0.36 0.36
ezekiel global business s... - 12.88 12.20 12.20 12.20
himanshu baid 8.24 8.24 7.81 7.80 7.80
himanshu baid (huf) 4.00 - 3.79 3.79 3.79
jai polypan pvt. ltd. 3.49 - 3.31 3.26 3.26
jugal kishore baid 2.38 2.38 2.25 2.25 2.25
madhu kothari 0.16 0.16 0.15 0.15 0.15
neha baid - - - - 1.01
polycure martech limited 0.01 0.01 0.01 0.01 0.01
rishi baid 10.18 10.18 9.64 9.59 9.59
rishi baid (huf) 2.90 - 2.74 2.74 2.74
shaily baid 1.24 1.24 1.17 1.17 1.17
shireen baid - - - - 1.11
smt. mukulika baid - - 3.02 3.02 3.02
vcb trading llp 3.69 3.69 3.50 3.49 3.49
vinay kothari 0.06 0.06 0.06 0.06 0.06
vishal baid 1.75 1.75 1.66 1.66 1.66
zetta matrix consulting l... 8.67 8.67 8.22 8.21 8.21
neha baid 1.07 1.07 1.01 1.01 -
shireen baid 1.17 1.17 1.11 1.11 -
himanshu baid (huf) - 4.00 - - -
jai polypan pvt. ltd - 3.49 - - -
rishi baid(huf) - 2.90 - - -
smt.mukulika baid 3.19 3.19 - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 46.85 33.97 37.44 37.56 37.56
axis max life insurance l... - - - - 1.94
lighthouse india fund iv ... - - 1.16 1.37 1.37
nirmala vinodkumar daga 2.18 2.12 1.84 1.80 1.80
quant mutual fund - quant... - - - - 3.35
shreans daga 1.53 1.53 1.45 1.43 1.43
smallcap world fund, inc 2.26 2.26 1.79 1.66 1.66
uti nifty midsmallcap 400... - - - - 1.62
varun daga 1.62 1.62 1.54 1.54 1.54
max life insurance co ltd... - - - 1.67 -
quant mutual fund - quant... - - 3.51 3.51 -
uti - healthcare fund 2.25 2.02 1.78 1.66 -
max life insurance compan... - - 1.71 - -
max life insurance compan... - 1.54 - - -
quant mutual fund - quant... - 3.43 - - -
ezekiel global business s... 12.88 - - - -
lighthouse india iii equi... 2.94 - - - -
max life insurance co. lt... 1.12 - - - -
quant mutual fund - quant... 2.12 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY ACTION
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q1FY25
TYPE QUARTER ACTION
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY21
Presentation FY2024

Company News

Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. Poly Medicure stock price today is Rs 2220.9. So, let’s look into Poly Medicure and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 256.1 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Poly Medicure has a Debt to Equity ratio of 0.1104 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Poly Medicure , the EPS growth was 40.5524 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Poly Medicure has OPM of 26.8975974051158 % which is a good sign for profitability.
     
  • ROE: Poly Medicure have a average ROE of 18.7387 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Poly Medicure is Rs 2220.9. One can use valuation calculators of ticker to know if Poly Medicure share price is undervalued or overvalued.
Last Updated on:
Brief about Poly Medicure
X